Cure Genetics, Boehringer to develop AAV vectors for gene therapy

By PBR Staff Writer

Chinese biotechnology firm Cure Genetics has partnered with Boehringer Ingelheim for the development of novel Adeno-Associated Virus (AAV) vectors to be used in gene therapies.